Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 3
1963 3
1964 2
1965 2
1967 3
1968 3
1970 2
1971 2
1973 4
1974 5
1975 4
1976 1
1977 2
1978 4
1979 8
1980 9
1981 6
1982 7
1983 12
1984 6
1985 3
1986 9
1987 4
1988 9
1989 2
1990 7
1991 11
1992 11
1993 17
1994 14
1995 18
1996 11
1997 9
1998 14
1999 11
2000 16
2001 20
2002 15
2003 21
2004 16
2005 20
2006 36
2007 16
2008 15
2009 28
2010 28
2011 21
2012 18
2013 24
2014 31
2015 36
2016 31
2017 23
2018 32
2019 52
2020 56
2021 58
2022 32
Text availability
Article attribute
Article type
Publication date

Search Results

805 results
Results by year
Filters applied: . Clear all
Page 1
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Sanz RG, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fernández de Larrea C, Belada D, Libby E, Matous JV, Motta M, Siddiqi T, Tani M, Trneny M, Minnema MC, Buske C, Leblond V, Trotman J, Chan WY, Schneider J, Ro S, Cohen A, Huang J, Dimopoulos M. Tam CS, et al. Among authors: chan wy. Blood. 2020 Oct 29;136(18):2038-2050. doi: 10.1182/blood.2020006844. Blood. 2020. PMID: 32731259 Free PMC article. Clinical Trial.
Snake venom toxins: toxicity and medicinal applications.
Chan YS, Cheung RCF, Xia L, Wong JH, Ng TB, Chan WY. Chan YS, et al. Among authors: chan wy. Appl Microbiol Biotechnol. 2016 Jul;100(14):6165-6181. doi: 10.1007/s00253-016-7610-9. Epub 2016 Jun 1. Appl Microbiol Biotechnol. 2016. PMID: 27245678 Review.
A research agenda for aging in China in the 21st century.
Fang EF, Scheibye-Knudsen M, Jahn HJ, Li J, Ling L, Guo H, Zhu X, Preedy V, Lu H, Bohr VA, Chan WY, Liu Y, Ng TB. Fang EF, et al. Among authors: chan wy. Ageing Res Rev. 2015 Nov;24(Pt B):197-205. doi: 10.1016/j.arr.2015.08.003. Epub 2015 Aug 22. Ageing Res Rev. 2015. PMID: 26304837 Free PMC article. Review.
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial.
Dimopoulos M, Sanz RG, Lee HP, Trneny M, Varettoni M, Opat S, D'Sa S, Owen RG, Cull G, Mulligan S, Czyz J, Castillo JJ, Motta M, Siddiqi T, Gironella Mesa M, Granell Gorrochategui M, Talaulikar D, Zinzani PL, Askari E, Grosicki S, Oriol A, Rule S, Kloczko J, Tedeschi A, Buske C, Leblond V, Trotman J, Chan WY, Michel J, Schneider J, Tan Z, Cohen A, Huang J, Tam CS. Dimopoulos M, et al. Among authors: chan wy. Blood Adv. 2020 Dec 8;4(23):6009-6018. doi: 10.1182/bloodadvances.2020003010. Blood Adv. 2020. PMID: 33284944 Free PMC article. Clinical Trial.
Effects of dietary and physical activity interventions on generic and cancer-specific health-related quality of life, anxiety, and depression in colorectal cancer survivors: a randomized controlled trial.
Ho M, Ho JWC, Fong DYT, Lee CF, Macfarlane DJ, Cerin E, Lee AM, Leung S, Chan WYY, Leung IPF, Lam SHS, Chu N, Taylor AJ, Cheng KK. Ho M, et al. Among authors: chan wyy. J Cancer Surviv. 2020 Aug;14(4):424-433. doi: 10.1007/s11764-020-00864-0. Epub 2020 Feb 18. J Cancer Surviv. 2020. PMID: 32072434 Free PMC article. Clinical Trial.
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.
de Bono JS, De Giorgi U, Rodrigues DN, Massard C, Bracarda S, Font A, Arranz Arija JA, Shih KC, Radavoi GD, Xu N, Chan WY, Ma H, Gendreau S, Riisnaes R, Patel PH, Maslyar DJ, Jinga V. de Bono JS, et al. Among authors: chan wy. Clin Cancer Res. 2019 Feb 1;25(3):928-936. doi: 10.1158/1078-0432.CCR-18-0981. Epub 2018 Jul 23. Clin Cancer Res. 2019. PMID: 30037818 Clinical Trial.
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Kim SB, Dent R, Im SA, Espié M, Blau S, Tan AR, Isakoff SJ, Oliveira M, Saura C, Wongchenko MJ, Kapp AV, Chan WY, Singel SM, Maslyar DJ, Baselga J; LOTUS investigators. Kim SB, et al. Among authors: chan wy. Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8. Lancet Oncol. 2017. PMID: 28800861 Free PMC article. Clinical Trial.
805 results